We are live on ! Find out more
SLDB icon

Solid Biosciences
SLDB

75 hedge funds and large institutions have $414M invested in Solid Biosciences in 2020 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 33 increasing their positions, 11 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

680% more capital invested

Capital invested by funds: $53M → $414M (+$361M)

241% more call options, than puts

Call options by funds: $5.24M | Put options by funds: $1.53M

200% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 11

108% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 12

21% more funds holding

Funds holding: 62 → 75 (+13)

0.56% more ownership

Funds ownership: 3.73% → 4.29% (+0.56%)

Holders
75
Holders Change
+13
Holders Change %
+20.97%
% of All Funds
1.33%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
25
Increased
33
Reduced
11
Closed
12
Calls
$5.24M
Puts
$1.53M
Net Calls
+$3.7M
Net Calls Change
+$3.7M

Top Buyers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
+$33.6M
2
RCM
RA Capital Management
Massachusetts
+$22.8M
3
PA
Perceptive Advisors
New York
+$17.1M
4
SCM
Suvretta Capital Management
New York
+$17.1M
5
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
+$13.4M

Top Sellers

Rank Fund Capital Flow
1
AG
Artal Group
Luxembourg
-$3.47M
2
BlackRock
BlackRock
New York
-$998K
3
EP
Eversept Partners
New York
-$623K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$283K
5
BCM
Bridgeway Capital Management
Texas
-$194K
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
$81.9M +$17.1M +270,270 +60%
RCM
2
RA Capital Management
Massachusetts
$75.6M +$22.8M +360,361 +118%
EC
3
EcoR1 Capital
California
$60.5M +$33.6M +531,847 New
BCLSI
4
Bain Capital Life Sciences Investors
Massachusetts
$53.5M +$13.4M +212,612 +82%
BC
5
Boxer Capital
California
$32.1M +$11.4M +180,180 +176%
SCM
6
Suvretta Capital Management
New York
$30.7M +$17.1M +270,270 New
BlackRock
7
BlackRock
New York
$15.1M -$998K -15,776 -11%
Vanguard Group
8
Vanguard Group
Pennsylvania
$12.7M +$3.76M +59,478 +113%
Millennium Management
9
Millennium Management
New York
$6.38M +$3.27M +51,708 +1,184%
IC
10
Ikarian Capital
Texas
$5.97M – – –
Two Sigma Investments
11
Two Sigma Investments
New York
$3.69M +$2.05M +32,410 New
Geode Capital Management
12
Geode Capital Management
Massachusetts
$3.54M +$493K +7,795 +33%
State Street
13
State Street
Massachusetts
$3.14M +$388K +6,140 +29%
Northern Trust
14
Northern Trust
Illinois
$2.57M +$238K +3,765 +20%
Two Sigma Advisers
15
Two Sigma Advisers
New York
$2.41M +$662K +10,466 +98%
Jacobs Levy Equity Management
16
Jacobs Levy Equity Management
New Jersey
$2.37M +$586K +9,265 +80%
ACM
17
Atika Capital Management
New York
$1.92M +$1.07M +16,858 New
D.E. Shaw & Co
18
D.E. Shaw & Co
New York
$1.72M -$283K -4,478 -23%
Morgan Stanley
19
Morgan Stanley
New York
$1.54M +$433K +6,846 +102%
BCM
20
Bridgeway Capital Management
Texas
$1.33M -$194K -3,066 -21%
JP Morgan Chase
21
JP Morgan Chase
New York
$1.22M +$219K +3,464 +47%
Bank of America
22
Bank of America
North Carolina
$974K +$148K +2,347 +38%
Wells Fargo
23
Wells Fargo
California
$795K +$250K +3,953 +130%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$769K +$94.2K +1,490 +28%
N
25
Nuveen
North Carolina
$767K +$78.5K +1,241 +23%
1
2 3 4

SLDB Hedge Fund Activity: Q4 2020 in Review

75 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Solid Biosciences (SLDB) for Q4 2020, worth a combined $414M — up 680% from $53M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new SLDB positions and 12 closed out — a net gain of 13 holders — while 33 added to existing stakes and 11 trimmed.

The largest buyer was EcoR1 Capital, opening a new position worth an estimated $33.6M. The largest seller was Artal Group, exiting entirely with an estimated $3.47M sold.

  • 75 institutional investors held Solid Biosciences (SLDB) as of Q4 2020, up from 62 in Q3 2020.
  • Funds reported $414M of Solid Biosciences stock for Q4 2020, up 680% quarter-over-quarter.
  • 25 funds opened new Solid Biosciences positions in Q4 2020 and 12 closed out, a net change of +13 holders.
  • The largest Solid Biosciences buyer in Q4 2020 was EcoR1 Capital, an estimated $33.6M added.
  • The largest Solid Biosciences seller in Q4 2020 was Artal Group, an estimated $3.47M sold.

Based on aggregated 13F filings for Q4 2020.